news
ESCMID publishes guidelines aimed at preventing build-up of biofilms
2 September 2015 | By Victoria White
ESCMID advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms...
List view / Grid view
Hit-to-Lead
news
MISSION Therapeutics appoints Dr Michael Koslowski as Chief Medical Officer
1 September 2015 | By Nick Jackson
Dr Koslowski brings over 15 years’ experience across biopharmaceutical research and development, specialising in drug target discovery and clinical validation...
news
Oncodrone to progress prostate cancer drug with €2.5m grant
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
news
Efficacy of iclaprim confirmed in independent laboratory study
24 August 2015 | By Victoria White
Motif Bio has announced the topline results of an independent report that show iclaprim is effective in vitro against a range of Gram-positive bacteria...
news
Janus Biotherapeutics and Roche collaborate on autoimmune disease therapies
20 August 2015 | By Victoria White
Janus Biotherapeutics has entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor...
news
New high-throughput screening method could speed drug discovery
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
news
Key paper on proteomics in the field of allergy published in the World Allergy Journal
10 August 2015 | By Charlotte Batchelor, Drug Target Review
Allergy Therapeutics has announced the publication of a key paper and featured article in the World Allergy Journal about proteomics in the field of allergy...
news
MorphoSys and G7 Therapeutics to develop antibodies targeting GPCRs
4 August 2015 | By Victoria White
MorphoSys and G7 Therapeutics have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs)...
news
Oncology treatment pipeline offers significant opportunities
4 August 2015 | By Victoria White
The oncology drug pipeline is far larger than any other therapy area with 6,484 products in active development across all indications...
news
Nanoparticles used to breach lung mucus barrier
4 August 2015 | By Victoria White
Researchers have used nanoparticles to breach the human airway mucus barrier of lung tissue - a finding that could lead to effective drug delivery systems...
news
AZ and Isis Pharmaceuticals to discover antisense drugs
3 August 2015 | By Victoria White
AstraZeneca and Isis Pharmaceuticals are to collaborate to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases...
news
Oxford Global’s Q&A session with Drug Discovery USA speaker Matthew Wagoner, a discovery safety specialist from AstraZeneca
31 July 2015 | By Oxford Global
In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous…
news
St Jude scientists identify new mechanism of p53-induced cell death
31 July 2015 | By Victoria White
Researchers have identified a new mechanism that the tumour suppressor protein p53 uses to trigger cell death via apoptosis...
news
Sygnature Discovery delivers clinical candidate CORT125134 to Corcept
30 July 2015 | By Victoria White
Sygnature Discovery has delivered CORT125134, a glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome, to Corcept...
news
Scientists discover exercise mimicking molecule ‘compound 14’
28 July 2015 | By Victoria White
Scientists have developed a molecule, called 'compound 14', that acts as an exercise mimic, which could potentially help treat type 2 diabetes and obesity...
